How to taper off Cymbalta (duloxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper Off Cymbalta (Duloxetine)

The most effective approach to tapering Cymbalta is a gradual reduction of approximately 10% of the original dose per week, with slower tapers (10% per month or less) recommended for patients who have been on Cymbalta long-term. 1

General Tapering Principles

  • Begin with a reduction of approximately 10% of the original dose per week as a reasonable starting point 1
  • For long-term users, consider slower tapers of 10% per month or less to minimize withdrawal symptoms 1
  • A gradual reduction in dose rather than abrupt cessation is strongly recommended to prevent discontinuation syndrome 2
  • Withdrawal symptoms typically appear within days of dose reduction and may last 1-3 days per step 1

Specific Tapering Protocol

  • For standard Cymbalta capsules, follow these steps:

    • First phase: Reduce by 10% of original dose weekly 1
    • Final stages: Consider alternating day dosing to achieve smaller dose reductions 1
    • Allow 1-2 weeks at each dose before further reduction to assess for withdrawal symptoms 1, 3
  • For patients on higher doses (60-120mg):

    • Initial reductions can be larger (e.g., from 60mg to 40mg or 30mg) 1
    • As doses get lower, make smaller reductions (e.g., from 30mg to 20mg to 10mg) 1
    • Consider using a hyperbolic tapering approach for the final stages, making progressively smaller reductions as the dose decreases 3, 4

Managing Withdrawal Symptoms

  • Common withdrawal symptoms include dizziness, headache, nausea, paresthesia, irritability, vomiting, insomnia, anxiety, and hyperhidrosis 2
  • If withdrawal symptoms become severe, pause tapering and restart when the patient is ready 1
  • Consider supportive medications to manage specific symptoms:
    • Short-term use of trazodone for anxiety or irritability 1
    • Sleep hygiene measures and possibly short-term sleep aids for insomnia 1
    • NSAIDs or acetaminophen for headaches and muscle aches 1

Special Considerations

  • Successful tapering may require several weeks to months, especially after long-term use 1, 5
  • Consider cognitive-behavioral therapy during tapering to increase rates of successful discontinuation 1
  • Protracted withdrawal may occur months after discontinuation, with symptoms including dysphoria, irritability, and insomnia 1

Common Pitfalls to Avoid

  • Avoid tapering too quickly, which significantly increases withdrawal risk 1, 3
  • Do not mistake withdrawal symptoms for recurrence of the original condition 1
  • Never discontinue Cymbalta abruptly, as this dramatically increases the risk of severe discontinuation syndrome 2, 5
  • Even with seemingly small doses (e.g., 20mg), the final steps of tapering should be gradual, as evidence suggests that the relationship between dose and effect is not linear 3, 4

When to Seek Additional Help

  • If symptoms of the original condition worsen significantly during tapering 1
  • If withdrawal symptoms are intolerable despite slowing the taper 1, 2
  • If resuming the previously prescribed dose does not alleviate intolerable withdrawal symptoms 2

References

Guideline

Tapering and Stopping Cymbalta (Duloxetine) Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antidepressant Withdrawal and Rebound Phenomena.

Deutsches Arzteblatt international, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.